These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3278878)

  • 21. Comparison of bronchodilator responses with bitolterol mesylate solution with the use of two different nebulizer systems in asthma.
    Kemp JP; Pinnas JL; Tinkelman DG; Meltzer EO; Campbell SC; Orgel HA; Welch MJ; Mingo TS
    J Allergy Clin Immunol; 1986 Mar; 77(3):509-15. PubMed ID: 3950254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective study of bitolterol mesylate in the treatment of conditions associated with reversible bronchospasm.
    Messina MS
    Adv Ther; 1995; 12(3):157-63. PubMed ID: 10155050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patients.
    Pinnas JL; Bernstein IL; Bronsky EE; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Nathan RA; Repsher LH; Bhatt BD
    J Allergy Clin Immunol; 1987 May; 79(5):768-75. PubMed ID: 3571768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination bronchodilator therapy.
    Shenfield GM
    Drugs; 1982 Nov; 24(5):414-39. PubMed ID: 6129123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative heart rate effects of oral administration of bitolterol, terbutaline and trimetoquinol in unanesthetized dogs.
    Nakanishi H; Nakahata N; Ito G; Yoshida H
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):185-8. PubMed ID: 6104851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influences of the route of administration on the metabolism and excretion of bitolterol, a new bronchodilator, in the rat.
    Aimoto T; Ito O; Kimura R; Murata T; Ito K
    Xenobiotica; 1979 Mar; 9(3):173-80. PubMed ID: 473792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral beta 2-selective adrenergic bronchodilators.
    Grassi V; Daniotti S; Schiassi M; Dottorini M; Tantucci C
    Int J Clin Pharmacol Res; 1986; 6(2):93-103. PubMed ID: 2873108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term tolerability of formoterol in chronic obstructive bronchopathies].
    Germouty J; Aubert J; Clavier J; Paramelle B; Voisin C
    Allerg Immunol (Paris); 1992 Nov; 24(9):342-7. PubMed ID: 1363036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bitolterol: a new bronchodilator in pediatrics].
    Calvo M; Arellano EM; Marín F
    Rev Chil Pediatr; 1988; 59(4):253-7. PubMed ID: 3075064
    [No Abstract]   [Full Text] [Related]  

  • 31. Salmeterol xinafoate: a review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.
    Brogden RN; Faulds D
    Allergol Immunopathol (Madr); 1992; 20(2):72-84. PubMed ID: 1359777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nocturnal asthma therapy. Inhaled bitolterol versus sustained-release theophylline.
    Zwillich CW; Neagley SR; Cicutto L; White DP; Martin RJ
    Am Rev Respir Dis; 1989 Feb; 139(2):470-4. PubMed ID: 2643904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting beta 2-agonists. Role in primary care asthma treatment.
    D'Urzo AD
    Can Fam Physician; 1997 Oct; 43():1773-7. PubMed ID: 9356758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models.
    Aparici M; Gómez-Angelats M; Vilella D; Otal R; Carcasona C; Viñals M; Ramos I; Gavaldà A; De Alba J; Gras J; Cortijo J; Morcillo E; Puig C; Ryder H; Beleta J; Miralpeix M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):497-509. PubMed ID: 22588259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical study on carbuterol (SKF 40383), a new selective bronchodilator agent aerosol: double blind comparison with isoproterenol aerosol.
    Saleeby PR; Ziskind MM
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):225-33. PubMed ID: 805017
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacology of long-acting beta-agonists.
    Johnson M
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):177-9. PubMed ID: 7648384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action.
    Celik G; Kayacan O; Beder S; Durmaz G
    Respiration; 1999; 66(5):434-9. PubMed ID: 10516540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchodilator effects of terbutaline and theophylline alone and in combination in patients with chronic obstructive lung disease.
    Baadsgaard O; Oberg B; Thomsen L; Klitgaard N; Simonsen E
    Allergol Immunopathol (Madr); 1985; 13(6):471-4. PubMed ID: 2870630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salmeterol versus slow-release theophylline in patients with reversible obstructive pulmonary disease.
    Taccola M; Bancalari L; Ghignoni G; Paggiaro PL
    Monaldi Arch Chest Dis; 1999 Aug; 54(4):302-6. PubMed ID: 10546469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.